Saba ACE and Saba GLP-1 work together to create a powerful combo that simplifies your weight loss journey
Semaglutide: The Single-Pathway Approach Wegovy relies on a well-established clinical history that began with the approval of Ozempic for Type 2 diabetes in 2017
Glutathion: Helps tissue building and repair, making chemicals and proteins needed in the body, and involves in immune system function
Effective monthly cost is total mandatory cost for the treatment period medication, membership, required consultations and labs, onboarding, shipping, dose surcharges divided by verified months of treatment supplied, excluding coupons, credits, and financing effects
In clinical trials of Wegovy, alopecia was reported in about 3% of adult patients on the medication versus 1% on placebo
Dulaglutide (Trulicity) is a once-weekly GLP-1 agonist approved for type 2 diabetes management